Institutional Ownership Sarepta Therapeutics, Inc. (SRPT)
This table provides information about the institutional ownership of Sarepta Therapeutics, Inc. (SRPT). We have compiled data on the 536 institutions that hold shares in the stock, with a total of 87.4 Million shares, which have been reported (via 13F filing form) to have a value of $9.47 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,324,404
shares
|
$1.1 Billion
0.04% of portfolio
|
Q2 2024
Added 73.22%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
9,085,456
shares
|
$966 Million
0.02% of portfolio
|
Q4 2024
Added 1.31%
|
|
Capital International Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
8,697,137
shares
|
$924 Million
0.21% of portfolio
|
Q4 2024
Added 38.95%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
4,328,323
shares
|
$460 Million
0.28% of portfolio
|
Q4 2024
Reduced 0.69%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,069,864
shares
|
$433 Million
0.02% of portfolio
|
Q4 2024
Reduced 4.7%
|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,865,100
shares
|
$305 Million
1.85% of portfolio
|
Q4 2024
Added 11.05%
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
2,555,555
shares
|
$272 Million
4.53% of portfolio
|
Q3 2024
Reduced 14.81%
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,068,771
shares
|
$220 Million
0.05% of portfolio
|
Q4 2024
Reduced 24.13%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
2,020,604
shares
|
$215 Million
0.02% of portfolio
|
Q4 2024
Reduced 8.11%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,956,583
shares
|
$208 Million
0.15% of portfolio
|
Q4 2024
Added 0.53%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,706,353
shares
|
$181 Million
0.02% of portfolio
|
Q4 2024
Added 0.59%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
1,663,349
shares
|
$177 Million
0.08% of portfolio
|
Q4 2024
Added 13.68%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,479,998
shares
|
$157 Million
0.03% of portfolio
|
Q4 2024
Added 306.4%
|
|
Groupama Asset Managment
Paris, I0 |
Feb 12, 2025 Q4 2024 |
1,300,000
shares
|
$138 Million
0.03% of portfolio
|
Q3 2024
New holding
|
|
Casdin Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,073,500
shares
|
$114 Million
11.23% of portfolio
|
Q2 2024
Added 0.42%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
1,046,025
shares
|
$111 Million
0.14% of portfolio
|
Q4 2024
Reduced 0.47%
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
1,038,861
shares
|
$110 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
Camber Capital Management LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$106 Million
2.81% of portfolio
|
Q4 2024
Added 29.03%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
991,655
shares
|
$105 Million
0.01% of portfolio
|
Q4 2024
Added 4.04%
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
963,400
shares
|
$102 Million
3.17% of portfolio
|
Q4 2024
Added 0.93%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
953,003
shares
|
$101 Million
0.13% of portfolio
|
Q2 2023
Reduced 21.46%
|
|
Alkeon Capital Management LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
853,845
shares
|
$90.7 Million
0.21% of portfolio
|
Q4 2024
Added 34.71%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
803,511
shares
|
$85.4 Million
0.01% of portfolio
|
Q4 2024
Added 22.55%
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
770,000
shares
|
$81.8 Million
4.37% of portfolio
|
Q4 2024
New holding
|
|
Erste Asset Management Gmb H
Vienna, C4 |
Feb 10, 2025 Q4 2024 |
708,248
shares
|
$75.3 Million
0.93% of portfolio
|
Q4 2024
Added 11.35%
|